Blood Flow Conditions and Sounds in AVFs
- Disease/Condition
- End Stage Renal Disease
- Drug/Device/Intervention
- MRI acquisition
- Study type
- Interventional
- Intervention type
- diagnostic test
- Primary sponsor
- Mario Negri Institute for Pharmacological Research
- Location
- Bergamo, Italy
- Phase
- N/A
- Start date
- Jul 01, 2024
- End date
- Jun 01, 2027
- Enrollment
- 15 participants
Correlation coefficient between LHPR and the vein's surface area with OSI 0.1
This is a prospective non-pharmacological interventional study aimed at investigating the
 relationship between the blood flow condition and the arteriovenous fistula (AVF) sound, with
 the ultimate aim of predicting the AVF clinical, in patients with end-stage renal disease
 (ESRD) who require the creation of a vascular access for extracorporeal circulation.
- Registry
- ClinicalTrials.gov
- Trial ID
- NCT06411353
- Type
- Non-Device Trial
Access comprehensive clinical trial information for NCT06411353 through Pure Global AI's free database. This phase not specified trial is sponsored by Mario Negri Institute for Pharmacological Research and is currently Not yet recruiting. The study focuses on End Stage Renal Disease. Target enrollment is 15 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.